安裝中文字典英文字典辭典工具!
安裝中文字典英文字典辭典工具!
|
- Science 37 (SNCE) Stock Price, News Analysis - MarketBeat
Should You Buy or Sell Science 37 Stock? Get The Latest SNCE Stock Analysis, Price Target, Earnings Estimates, Headlines, and Short Interest at MarketBeat Shares of Science 37 reverse split on the morning of Friday, December 8th 2023 (NASDAQ:SNCE) was last updated on 6 17 2025 by MarketBeat com Staff From Our Partners The End of
- Science 37 Holdings, Inc. (SNCE) Stock Price, Quote, News Analysis . . .
Science 37 down 12%, will effect 1-for-20 reverse stock split to regain Nasdaq compliance SA News Tue, Dec 05, 2023 Science 37 Holdings, Inc (SNCE) Q3 2023 Earnings Call Transcript
- eMed Completes Tender Offer for All Outstanding Shares of . . . - Science 37
MIAMI, March 12, 2024 PRNewswire -- eMed, LLC ("eMed") today announced the successful completion of the previously announced tender offer by its wholly-owned subsidiary, Marlin Merger Sub Corporation ("Purchaser"), for all the outstanding shares of common stock, par value $0 0001 per share, of Science 37 Holdings, Inc (NASDAQ: SNCE) ("Science 37") at a price of USD 5 75 per share
- Science 37 Holdings, Inc. Announces 1-for-20 Reverse Stock - GlobeNewswire
Science 37 Holdings, Inc Announces 1-for-20 Reverse Stock Split effective December 8, 2023
- Science 37 Holdings Inc Stock Price Today | NASDAQ: SNCE Live . . .
View today's Science 37 Holdings Inc stock price and latest SNCE news and analysis Science 37 Holdings Announces 1-for-20 Reverse Stock Split effective December 8, 2023 Science 37 Holdings
- Science 37 Holdings (SNCE) Announces 1-for-20 Reverse Stock Split . . .
Science 37 Holdings, Inc (Nasdaq: SNCE) (“Science 37” or the “Company”), the clinical research industry-leading Metasite™, announced today that it will effect a 1-for-20 reverse stock
- Science 37 to be Acquired by eMed, Expanding Access to Patients and . . .
Science 37 stockholders to receive $5 75 per share in cashRESEARCH TRIANGLE PARK, N C , Jan 29, 2024 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc (Nasdaq: SNCE) (the “Company” or “Science
- Science 37 Holdings, Inc. Announces 1-for-20 Reverse Stock . . . - Nasdaq
--Science 37 Holdings, Inc , the clinical research industry-leading Metasite™, announced today that it will effect a 1- for-20 reverse stock split of its outstanding common stock, par value $0
|
|
|